168 related articles for article (PubMed ID: 18434070)
1. Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer.
Duric VM; Butow PN; Sharpe L; Heritier S; Boyle F; Beith J; Wilcken NR; Coates AS; Simes RJ; Stockler MR
Patient Educ Couns; 2008 Aug; 72(2):239-45. PubMed ID: 18434070
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer.
Duric VM; Butow PN; Sharpe L; Boyle F; Beith J; Wilcken NR; Heritier S; Coates AS; John Simes R; Stockler MR
Psychooncology; 2007 Jan; 16(1):48-59. PubMed ID: 16856128
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?
Blinman P; Duric V; Nowak AK; Beale P; Clarke S; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler M
Eur J Cancer; 2010 Jul; 46(10):1800-7. PubMed ID: 20137908
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting patients' perceptions of choice regarding adjuvant chemotherapy for breast cancer.
Jansen SJ; Otten W; Stiggelbout AM
Breast Cancer Res Treat; 2006 Sep; 99(1):35-45. PubMed ID: 16541318
[TBL] [Abstract][Full Text] [Related]
5. Partner understanding of the breast and prostate cancer experience.
Carlson LE; Ottenbreit N; St Pierre M; Bultz BD
Cancer Nurs; 2001 Jun; 24(3):231-9. PubMed ID: 11409068
[TBL] [Abstract][Full Text] [Related]
6. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
Jansen SJ; Kievit J; Nooij MA; de Haes JC; Overpelt IM; van Slooten H; Maartense E; Stiggelbout AM
Br J Cancer; 2001 Jun; 84(12):1577-85. PubMed ID: 11401308
[TBL] [Abstract][Full Text] [Related]
7. Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
Duric VM; Stockler MR; Heritier S; Boyle F; Beith J; Sullivan A; Wilcken N; Coates AS; Simes RJ
Ann Oncol; 2005 Nov; 16(11):1786-94. PubMed ID: 16126738
[TBL] [Abstract][Full Text] [Related]
8. Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
Blinman P; Hughes B; Crombie C; Christmas T; Hudson M; Veillard AS; Muljadi N; Millward M; Wright G; Flynn P; Windsor M; Stockler M; McLachlan SA;
Eur J Cancer; 2015 Aug; 51(12):1529-37. PubMed ID: 26059196
[TBL] [Abstract][Full Text] [Related]
9. Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
; Blinman P; Mileshkin L; Khaw P; Goss G; Johnson C; Capp A; Brooks S; Wain G; Kolodziej I; Veillard AS; O'Connell R; Creutzberg CL; Stockler MR
Br J Cancer; 2016 Nov; 115(10):1179-1185. PubMed ID: 27764842
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life during adjuvant treatment for breast cancer among postmenopausal women.
Browall M; Ahlberg K; Karlsson P; Danielson E; Persson LO; Gaston-Johansson F
Eur J Oncol Nurs; 2008 Jul; 12(3):180-9. PubMed ID: 18343197
[TBL] [Abstract][Full Text] [Related]
11. Justifying adjuvant chemotherapy in breast cancer: a survey of women and healthcare professionals.
Sweeney KJ; Ryan E; Canney M; O'Daly BJ; Kerin MJ
Eur J Surg Oncol; 2007 Sep; 33(7):838-42. PubMed ID: 17267166
[TBL] [Abstract][Full Text] [Related]
12. Explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients.
Jansen SJ; Otten W; Baas-Thijssen MC; van de Velde CJ; Nortier JW; Stiggelbout AM
J Clin Oncol; 2005 Sep; 23(27):6623-30. PubMed ID: 16170169
[TBL] [Abstract][Full Text] [Related]
13. Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment.
Niikura N; Kimura M; Iwamoto T; Hayashi N; Shintoku J; Saito Y; Suzuki Y; Tokuda Y
Breast Cancer; 2013 Jan; 20(1):67-74. PubMed ID: 22109640
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
15. Couples who get closer after breast cancer: frequency and predictors in a prospective investigation.
Dorval M; Guay S; Mondor M; Mâsse B; Falardeau M; Robidoux A; Deschênes L; Maunsell E
J Clin Oncol; 2005 May; 23(15):3588-96. PubMed ID: 15908669
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?
Simes RJ; Coates AS
J Natl Cancer Inst Monogr; 2001; (30):146-52. PubMed ID: 11773309
[TBL] [Abstract][Full Text] [Related]
17. Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile.
Duric V; Stockler M
Lancet Oncol; 2001 Nov; 2(11):691-7. PubMed ID: 11902540
[TBL] [Abstract][Full Text] [Related]
18. Depression and perceptions of quality of life of breast cancer survivors and their male partners.
Rabin EG; Heldt E; Hirakata VN; Bittelbrunn AC; Chachamovich E; Fleck MP
Oncol Nurs Forum; 2009 May; 36(3):E153-8. PubMed ID: 19403443
[TBL] [Abstract][Full Text] [Related]
19. Side effects of adjuvant chemotherapy: perceptions of node-negative breast cancer patients.
Beisecker A; Cook MR; Ashworth J; Hayes J; Brecheisen M; Helmig L; Hyland S; Selenke D
Psychooncology; 1997 Jun; 6(2):85-93. PubMed ID: 9205966
[TBL] [Abstract][Full Text] [Related]
20. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
